The aim of the present study is to investigate the effect of Ammonio Methacrylate released linearly along with time throughout the whole dissolution process in phosphate buffer (p H 6.8) and it was also revealed that, in all cases the release of diclofenac sodium followed zero order kinetics.
Introduction
The pellet type of sustained-release preparation is often referred to as bead-type preparation. In general the beads are prepared by coating drug powder onto perforated cores called nonpareil seeds. The drug-coated beads generally provide a rapid-release carrier for the drug depending on the coating solution used in coating the drug. Once the drug beads are prepared, they may be further coat ed with a protective coating to allow a sustained or prolonged release of the drug (Andrew and Shargel 1941) . A major advantage of pellet dosage form is that the pellets are less sensitive to the effect of stomach emptying. Because there are numerous pellets within a capsule, some pellets will gradually reach the small intestine and deliver the drug; where as a single tablet may be delayed in the stomach for a long time due to erratic stomach emptying (Andrew and Shargel 1941) . The fluctuating drug concentrations in blood and tissues caused by conventional dosage forms lead to an insufficient influence on the mechanisms of disease and are related to the excessive use of drug. Various oral dosage forms able to control the rate and extent of drug delivery into systemic circulation have been prepared and studied (Bidah and Vergnaud 1991 , Bravo et al. 2002 , Ford et al. 2000 , Jayasagar et al. 2001 .
Aqueous film-coating dispersions generally consist of polymeric colloidal particles, a plasticizer, a pigment, and an anti-adherent agent. Most polymers employed for the film coating of pellets and tablets are brittle at room temperature and require the use of plasticizers to improve their handling and processing (Chuanbin and James 2001) . The most widely used aqueous polymer dispersions for sustained-release coating applications are either ethylcellulose -based (Aquacoat ECD, Surelease) or acrylate-based i.e. polymethacrylates (Eudragit RL 30 D, Eudragit RS 30 D, Eudragit NE 30 D and others) products. Because of ethylcellulose's relatively high glass-transition temperature (Tg) and pseudolatex nature, ethylcellulose aqueous dispersions require adequate plasticization, with the end product needing further curing steps. Although Eudragit products are true latex with low Tg's, particle coalescence at room temperature is still slow and incomplete, necessitating accelerated curing conditions and/or the incorporation of watersoluble additives (Augsburger et al. 2000) . Polymethacrylates are primarily used in oral capsule and tablet formulations as film coating agents (Dreher and Lehmann 1973 , Dreher and Lehmann 1981 , Obi and Okor 1990 . Depending on the type of polymer used, films of different solubility characteristics can be produced. Eudragit RL 30 D and Eudragit RS 30 D are aqueous dispersion of copolymers of acrylic acid and methacrylic acid esters with a low content of quaternary ammonium groups (Kibbe 2000 , Lehmann 1996 . The dispersions contain 30 % polymer. The quaternary groups occur as salts and are responsible for the permeability of films made from these polymers. Films prepared from Eudragit RL 30 D are readily permeable to water and to dissolve active substances, whereas films prepared from Eudragit RS 30 D are less permeable to water and release the active substances through diffusion (Abmus et al. 2001 , Lehmann 1996 . Film coatings prepared from both polymers give pH-independent release of active substance. Plasticizers are usually added to improve film properties (Kibbe 2000 (Fig. 1 ).
Then coating suspension was prepared by using Eudragit RS 30 D and Eudragit RL 30 D (5 % polymer (w/w) on dry basis at a ratio of 5:1 with reference to 360.00g drug loaded beads), purified talc, titanium dioxide, triethyl citrate and water (Table I) . Drug loaded pellets were loaded in the fluid bed coater and coating suspension was sprayed. After completion of spraying, the coated pellets were dried at 60 O C for 5 hours in hot air oven and sieved through 18 and 22 mesh to get the desired size (18/22) of the diclofenac sodium sustained release pellets. Same process was applied for 10 %, 15 %, 20 %, 25 % and 30 % polymer load (Table I) .
In vitro dissolution study
The dissolution of diclofenac sodium sustained release pellets was studied by Erweka (Germany) dissolution tester USP (XXVIII) using USP apparatus 1 (Basket method). Diclofenac sodium sustained release pellets equivalent to 100 mg of diclofenac sodium was poured in 900 ml of 0.1 N hydrochloric acid medium at 37 O ± 0.5 O C with a rotation of 100 rpm for 2 hours. At the end of 2 hours the media was removed and drug content was determined spectrophotometrically at 276 nm. Then 900 ml of phosphate buffer (Na 3 PO 4 ) p H 6.8 was placed in each vessel and rotated at 100 rpm at 37 O ± 0.5 O C for 10 hours. 5ml samples were drawn every one hour and replaced by fresh medium to maintain the volume constant and drug content was determined spectrophotometrically (Shimadzu, UV-1650PC, Japan) at 276 nm.
Results and Discussion
Diclofenac sodium was loaded on nonpareil seeds by powder layering method and finally coated with aqueous dispersion of acrylic polymers such as Eudragit RS 30 D and Eudragit RL 30 D combination using fluid bed coater. The drug release was studied by in vitro dissolution using USP basket method. Initially the color of the drug-loaded pellets was white and the size was spherical but after coating with acrylic polymers pellets become off-white but shape remained same (Table II) . During beads preparation by powder layering process total yield was found 85.77 % due to some loss of raw materials mainly from adhesion of wet mass with the machine surfaces that should be considered during manufacturing (Table II) but in case of coating the yield was increased gradually which indicates that very few agglomeration or powdering was occurred in the coating process. The LOD value was increased along with increase in polymer load, which indicates that polymers form stable film around the pellets that inhibits the moisture present in core to expel out through the polymeric membranes. It was also expressed that bulk density of the coated pellets increased harmonically along with polymer load (Table  II ) which reflects that volume of the pellets might not be increased proportionally along with increase in weight of pellets due to polymer load.
When diclofenac sodium loaded pellets were coated with 5 % to 30 % of the combination Absar, Kibria and Jalil 243 Table II , then it was revealed that the polymers have significant release retarding effect of drug in acid media and from all formulations maximum 2.87 % drug was released at first 2 hours (Fig. 2) . In the buffer media, it was found that the drug release decreases gradually along with the increase in percent of polymer load and in all cases it was observed that the initial drug release was slower than the terminal drug release which can be governed by the physico-chemical properties of Eudragit RS 30 D (Abmus et al. 2001 , Kibbe 2000 , Lehmann 1996 . It was also revealed that when diclofenac sodium pellets was coated with the 5 % polymer load then about 45 % drug was released at first hour which indicates the burst release of drug but this possibility was decreased gradually from 10 % to 30 % polymer load (Fig. 3) . With 10 % polymer load about 28 % drug was released at first hour and about 50 % drug was released at 5th hour but only 65 % drug was released within 10 hours (Fig. 4) . Again for higher percent polymer load (15 %) only 18 % drug was released at first hour whereas 45 % drug was released within 10 hours. Simultaneously the drug release was decreased markedly with higher percent of polymer level (Fig. 4) . While the percent of polymer increased the low permeability nature of Eudragit RS 30 D (Abmus et al. 2001) was increased simultaneously which Absar, Kibria and Jalil 245 might play the role to retard the release of the drug vigorously and a big difference in drug release was observed between 15 % to 20 % or more polymer load throughout the whole dissolution process (Fig. 4) . But the low permeability properties of Eudragit RS 30 D as well as the high permeability properties of Eudragit RL 30 D may lead the drug to release linearly throughout the whole dissolution process in aqueous media at p H 6.8 (Abmus et al. 2001 , Al-Taani and Tashtoush 2003 , Cox et al. 1998 to sustain the release of diclofenac sodium from the coated pellets and better sustained effect was found in case of 5 % and 10 % polymer load with a good dissolution profile. Only about 10 % drug was released at 10 hours while the polymer load was 25 % (r 2 = 0.9284) and 30 % (r 2 = 0.9466).
Conclusion
Diclofenac sodium loaded pellets were prepared by powder layering technology and the in vitro release profile of drug was investigated. The physical properties of pellets influenced by the polymer level. The release profile of drug was found to be a function of polymer load as well as the physico-chemical nature of the polymeric materials. The combination of two different acrylic polymers showed the better effect on the release kinetics of drug with lower percent of polymer load (5-15 %) to sustain the release of drug over a period of time with better dissolution profile as well as better linearity in drug release kinetics. So it is possible to modify the release profile of drug from diclofenac containing coated pellets by choosing suitable polymeric combinations according to the desired drug concentration at the target site of drug absorption. This process can be applied for commercial manufacturing of 
